{"id":17287,"date":"2022-08-24T04:35:50","date_gmt":"2022-08-24T04:35:50","guid":{"rendered":"http:\/\/www.pidsphil.org\/home\/?page_id=17287"},"modified":"2025-06-14T03:29:34","modified_gmt":"2025-06-14T03:29:34","slug":"journal-2022-vol-23-no-1-original-articles-1","status":"publish","type":"page","link":"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/","title":{"rendered":"Journal 2022 Vol.23 No.1 Original Articles 1"},"content":{"rendered":"<p><strong><span style=\"color: #800000;\">Journal 2022 Vol.23 No<\/span><span style=\"color: #800000;\">.1<\/span><\/strong><br \/>\n<strong>A Systematic Review and Meta-Analysis on the Safety and Efficacy of Second Dose Immunoglobulin Versus High Dose Pulse Methylprednisolone in Refractory Kawasaki Disease<\/strong><br \/>\n<strong><em>Catherine Uy Cano, M.D., Teldy Ley-Chua, M.D. and Robert Dennis Garcia, M.D.<\/em><br \/>\nAbstract<br \/>\nBackground:<\/strong> There is limited information available regarding the management of IVIG-refractory Kawasaki Disease (KD).<br \/>\n<strong>Objective:<\/strong> This study aimed to evaluate the safety and efficacy of a second intravenous immunoglobulin (IVIG) infusion versus intravenous methylprednisolone (IVMP) in patients with IVIG-refractory KD.<br \/>\n<strong>Methodology:<\/strong> Cochrane Library, PubMed, Medline, Elsevier (Science Direct), Springer Link and BMJ databases were searched from May 1, 2020 to December 31, 2020. We included randomized controlled trials (RCTs) and high-quality prospective and retrospective studies, with population restricted to children 0 months to 18 years, with KD refractory to initial IVIG at 2g\/kg, who remained febrile for 24-48 hours after completion of initial IVIG, and who received second-line monotherapy with either a second dose IVIG or IVMP. We conducted a meta-analysis using Review Manager [RevMan] 5.4.1 software.<br \/>\n<strong>Results:<\/strong> A total of six studies (n=188 patients) were analyzed. The incidence of coronary artery lesions was comparable between a second dose of IVIG and IVMP (RR 0.82, 0.34-1.96, P=0.66) in patients with IVIG-refractory KD. The rate of fever resolution to a second IVIG, compared to IVMP, was not significantly different between groups (RR 0.97, 0.84-1.13, P=0.72). There was a significantly higher incidence of adverse events in the IVMP group (RR 0.42, 0.26-0.57, P=0.0002), but these were all transient and resolved without further treatment.<br \/>\n<strong>Conclusion:<\/strong> There is no significant difference in the incidence of coronary artery lesions and rate of fever resolution post-retreatment with a second dose of IVIG versus IVMP in IVIG-refractory KD. More adverse events were reported in the IVMP group.<br \/>\n<strong>Keywords:<\/strong>\u00a0Mucocutaneous Lymph Node Syndrome, Kawasaki Disease, Refractory Kawasaki Disease, Immunosuppressant,<br \/>\nIntravenous Immunoglobulin, Methylprednisolone, Second IVIG Infusion<br \/>\n<a href=\"https:\/\/doi.org\/10.56964\/pidspj20222301005\"><strong>https:\/\/doi.org\/10.56964\/pidspj20222301005<\/strong><\/a><br \/>\n<strong><a href=\"https:\/\/www.pidsphil.org\/home\/wp-content\/uploads\/2022\/12\/005_PIDSP-vol-23-no-1_CANO_IVIG.pdf\" target=\"_\" rel=\"noopener\">View Full Article in PDF format<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Journal 2022 Vol.23 No.1 A Systematic Review and Meta-Analysis on the Safety and Efficacy of Second Dose Immunoglobulin Versus High Dose Pulse Methylprednisolone in Refractory Kawasaki Disease Catherine Uy Cano, M.D., Teldy Ley-Chua, M.D. and Robert Dennis Garcia, M.D. Abstract Background: There is limited information available regarding the management of IVIG-refractory Kawasaki Disease (KD). Objective:  [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-17287","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Journal 2022 Vol.23 No.1 Original Articles 1 - Pediatric Infectious Disease Society of the Philippines<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Journal 2022 Vol.23 No.1 Original Articles 1 - Pediatric Infectious Disease Society of the Philippines\" \/>\n<meta property=\"og:description\" content=\"Journal 2022 Vol.23 No.1 A Systematic Review and Meta-Analysis on the Safety and Efficacy of Second Dose Immunoglobulin Versus High Dose Pulse Methylprednisolone in Refractory Kawasaki Disease Catherine Uy Cano, M.D., Teldy Ley-Chua, M.D. and Robert Dennis Garcia, M.D. Abstract Background: There is limited information available regarding the management of IVIG-refractory Kawasaki Disease (KD). Objective: [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Pediatric Infectious Disease Society of the Philippines\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-14T03:29:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2022-vol-23-no-1-original-articles-1\\\/\",\"url\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2022-vol-23-no-1-original-articles-1\\\/\",\"name\":\"Journal 2022 Vol.23 No.1 Original Articles 1 - Pediatric Infectious Disease Society of the Philippines\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/#website\"},\"datePublished\":\"2022-08-24T04:35:50+00:00\",\"dateModified\":\"2025-06-14T03:29:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2022-vol-23-no-1-original-articles-1\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2022-vol-23-no-1-original-articles-1\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2022-vol-23-no-1-original-articles-1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal 2022 Vol.23 No.1 Original Articles 1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/#website\",\"url\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/\",\"name\":\"Pediatric Infectious Disease Society of the Philippines\",\"description\":\"Pediatric Infectious Disease Society of the Philippines\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Journal 2022 Vol.23 No.1 Original Articles 1 - Pediatric Infectious Disease Society of the Philippines","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/","og_locale":"en_US","og_type":"article","og_title":"Journal 2022 Vol.23 No.1 Original Articles 1 - Pediatric Infectious Disease Society of the Philippines","og_description":"Journal 2022 Vol.23 No.1 A Systematic Review and Meta-Analysis on the Safety and Efficacy of Second Dose Immunoglobulin Versus High Dose Pulse Methylprednisolone in Refractory Kawasaki Disease Catherine Uy Cano, M.D., Teldy Ley-Chua, M.D. and Robert Dennis Garcia, M.D. Abstract Background: There is limited information available regarding the management of IVIG-refractory Kawasaki Disease (KD). Objective: [...]","og_url":"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/","og_site_name":"Pediatric Infectious Disease Society of the Philippines","article_modified_time":"2025-06-14T03:29:34+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/","url":"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/","name":"Journal 2022 Vol.23 No.1 Original Articles 1 - Pediatric Infectious Disease Society of the Philippines","isPartOf":{"@id":"https:\/\/www.pidsphil.org\/home\/#website"},"datePublished":"2022-08-24T04:35:50+00:00","dateModified":"2025-06-14T03:29:34+00:00","breadcrumb":{"@id":"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.pidsphil.org\/home\/journal-2022-vol-23-no-1-original-articles-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pidsphil.org\/home\/"},{"@type":"ListItem","position":2,"name":"Journal 2022 Vol.23 No.1 Original Articles 1"}]},{"@type":"WebSite","@id":"https:\/\/www.pidsphil.org\/home\/#website","url":"https:\/\/www.pidsphil.org\/home\/","name":"Pediatric Infectious Disease Society of the Philippines","description":"Pediatric Infectious Disease Society of the Philippines","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pidsphil.org\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages\/17287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/comments?post=17287"}],"version-history":[{"count":10,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages\/17287\/revisions"}],"predecessor-version":[{"id":19959,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages\/17287\/revisions\/19959"}],"wp:attachment":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/media?parent=17287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}